FLT3 and acute myeloid leukemia: As presented in Table 1, crotonoside selectively inhibited the viability of AML cell line MV4-11, MOLM-13 (with FLT3-ITD mutant) and KG-1 (without FLT3-ITD mutant) in a dose-dependent manner with an IC50 of 11.6±2.7 μM, 12.7±3.3 μM and 17.2±4.6 μM, respectively.